Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STANDARD BIOTOOLS INC.LAB · Entity 6116 | Director | June 15, 2022 | June 17, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STANDARD BIOTOOLS INC.
Report date June 15, 2022 · Filed June 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 59,288 |
Reported balance
After 2022-06-15 transaction · row 1
1 source rowRow 1 · 2022-06-15 · Grant · Acquired 30,914 · Balance 59,288 F1: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.86 · Expires 2032-06-15 | Direct | 42,571 |
Reported balance
After 2022-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-06-15 · Grant · Acquired 42,571 · Balance 42,571 F2: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders.
F2: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2022 Filed Jun 17, 2022 22:11 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 42,571 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001162194-22-000082 · wf-form4_165550386102701.xml · derivative · entry 2 Colston Bill · CIK 0001783315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,571 Underlying: Common Stock · 42,571 shares Expires 2032-06-15 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:11 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantCommon Stock | 30,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000082 · wf-form4_165550386102701.xml · nonDerivative · entry 1 Colston Bill · CIK 0001783315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,288 F1 · shares: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:31 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 15,402 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001162194-21-000061 · wf-form4_162215100363251.xml · derivative · entry 2 Colston Bill · CIK 0001783315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,402 Underlying: Common Stock · 15,402 shares Expires 2031-05-25 F2 · derivative.exercise_date: The Option became exercisable in twelve equal monthly increments beginning on June 25, 2021. Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:31 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantCommon Stock | 10,342 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000061 · wf-form4_162215100363251.xml · nonDerivative · entry 1 Colston Bill · CIK 0001783315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,374 F1 · shares: The Restricted Stock Units vest in full on the earlier to occur of May 25, 2022 and one day prior to the date of the Company's next annual meeting of stockholders. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 19:59 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 20,993 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001162194-20-000083 · wf-form4_159311515446941.xml · derivative · entry 2 Colston Bill · CIK 0001783315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,993 Underlying: Common Stock · 20,993 shares Expires 2030-06-23 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly increments beginning on July 23, 2020. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 19:59 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantCommon Stock | 13,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000083 · wf-form4_159311515446941.xml · nonDerivative · entry 1 Colston Bill · CIK 0001783315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,032 F1 · shares: The Restricted Stock Units vest in full on the earlier to occur of June 23, 2021 and one day prior to the date of the Company's next annual meeting of stockholders. Read SEC document |
| July 23, 2019 Filed Jul 26, 2019 01:18 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 7,476 | $0.00 Strike: $11.54 | $0.00 |
DisclosureSEC source: 0001162194-19-000064 · wf-form4_156410389973857.xml · derivative · entry 2 Colston Bill · CIK 0001783315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,476 Underlying: Common Stock · 7,476 shares Expires 2029-07-23 F2 · derivative.exercise_date: The Option becomes exercisable in four equal yearly installments beginning on July 23, 2020. Read SEC document |
| July 23, 2019 Filed Jul 26, 2019 01:18 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantCommon Stock | 4,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000064 · wf-form4_156410389973857.xml · nonDerivative · entry 1 Colston Bill · CIK 0001783315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,663 F1 · shares: Represents Restricted Stock Units that vest in four equal yearly installment beginning on July 23, 2020. Read SEC document |
| July 23, 2019 Filed Aug 9, 2019 01:04 UTC Amendment | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 8,724 | $0.00 Strike: $11.54 | $0.00 |
DisclosureSEC source: 0001162194-19-000072 · wf-form4a_156531268163941.xml · derivative · entry 1 Colston Bill · CIK 0001783315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,724 Underlying: Common Stock · 8,724 shares Expires 2029-07-23 F1 · shares: The number of shares was reported incorrectly on the original Form 4 due to an administrative error. F2 · derivative.exercise_date: The Option becomes exercisable in four equal yearly installments beginning on July 23, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.